Invitation to Annual General Meeting of Shareholders


Invitation to Annual General Meeting of Shareholders The Board of Directors of Active Biotech AB (publ) has today issued a notification of the Annual General Meeting, which is to take place at 17.00 on 29 March 2001 at the Scandic Star Hotel, Glimmervägen 5, in Lund. The notification is published in today's editions of Sydsvenskan, Svenska Dagbladet and Post- och Inrikes Tidningar. ACTIVE BIOTECH AB (PUBL) THE BOARD OF DIRECTORS Active Biotech AB is a biotechnics company focusing on research and development of medicines and vaccines. Our expertise lies in the knowledge of the human immune defence system. We have a high-quality project portfolio and financial strength. The most important products and projects are medicines for multiple sclerosis (SAIK-MS) and cancer (TTS), the SBL Cholera Vaccine, and Dukoral and ETEC vaccines against tourist diarrhoea. Active Biotech's turnover was MSEK 280 in 2000. Active Biotech AB (publ) P.O. Box 724, SE-220 07 Lund, Sweden Telephone: +46 46 19 20 00 Telefax: +46 46 19 20 50 E-mail: info@activebiotech.com Invitation to Annual General Meeting of Shareholders in Active Biotech AB (publ) The shareholders in Active Biotech AB (publ) are hereby invited to attend the Annual General Meeting of Shareholders to be held at 17.00 on Thursday, 29 March at the Scandic Star Hotel, Glimmervägen 5, in Lund. NOTIFICATION Shareholders, who wish to participate in the Annual General Meeting of Shareholders, must both be entered under their own names (not registered as a trustee) in the register of shareholders maintained by Värdepapperscentralen VPC AB on behalf of the Company, as of 19 March 2001, and notify the Company of their intention to participate in the Annual General Meeting of Shareholders by no later than 4 pm on Friday, 23 March 2001. Notification of participation in the Annual General Meeting of Shareholders shall be made in writing to Active Biotech AB (publ), Att: Susanne Jönsson, P.O. Box 724, SE-220 07 Lund, by telephone on +46 (0)46 19 20 00, by telefax on +46 (0)46 19 20 50 or via e-mail to info@activebiotech.com. Upon notification the following information shall be provided: name, personal identity number/corporate registration number, address and telephone number, together with numbers and type(s) of shares. In order to possess the right to participate in the Annual General Meeting of Shareholders, shareholders whose shares are registered in trust through a bank's trust department or individual stockbroker, must temporarily register the shares with VPC in their own name. Such re-registration must be completed by no later than Monday, 19 March 2001. ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/02/27/20010227BIT00400/bit0002.doc http://www.bit.se/bitonline/2001/02/27/20010227BIT00400/bit0002.pdf

About Us

Active Biotech's activity is in the biomedical area. The company focuses on R & D.